摘要:
The present invention concerns cell-penetrating peptides which comprise an amino acid sequence consisting of GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8(SEQ ID No: 1), wherein X1 is A, L or G, X2 is W or none, X3 is R or K, X4 is K, L or S, X5 is L or K, X6 is R or W, X7 is K or S, and X8 is A, V or Q, and X9 is W, F or Y. These CPPs can be used as vectors for delivering nucleic acids and/or proteins and/or peptides to cells, in vitro or in vivo.
摘要翻译:本发明涉及包含由GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8(SEQ ID No:1)组成的氨基酸序列的细胞穿透肽,其中X1为A,L或G,X2为W或无,X3为R或K,X4为K, L或S,X 5为L或K,X 6为R或W,X 7为K或S,X 8为A,V或Q,X 9为W,F或Y.这些CPP可用作递送核酸 酸和/或蛋白质和/或肽在体外或体内。
摘要:
The present invention concerns cell-penetrating peptides which comprise an amino acid sequence consisting of GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8 (SEQ ID No: 1), wherein X1 is A, L or G, X2 is W or none, X3 is R or K, X4 is K, L or S, X5 is L or K, X6 is R or W, X7 is K or S, and X8 is A, V or Q, and X9 is W, F or Y. These CPPs can be used as vectors for delivering nucleic acids and/or proteins and/or peptides to cells, in vitro or in vivo.
摘要翻译:本发明涉及包含由GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8(SEQ ID No:1)组成的氨基酸序列的细胞穿透肽,其中X1为A,L或G,X2为W或无,X3为R或K,X4为K, L或S,X 5为L或K,X 6为R或W,X 7为K或S,X 8为A,V或Q,X 9为W,F或Y.这些CPP可用作递送核酸 酸和/或蛋白质和/或肽在体外或体内。
摘要:
The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections.
摘要:
The invention is drawn to a novel class of drugs directed against HIV, comprising a peptide or analog comprising a decapeptide, said decapeptide containing (from N-terminus to the C-terminus) a basic amino acid in position 1, an acidic amino acid in positions 2 and 5, and a tryptophan in positions 4, 7, and 8, and to a method of treatment of HIV infections, in particular multidrug-resistant HIV infections.